Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation-Reference-Cited by-同舟云学术

Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

Published:2020-05-09 Issue:7 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Oesterheld Javier E.¹,Reed Damon R.²,Setty Bhuvana A.³^ORCID,Isakoff Michael S.⁴^ORCID,Thompson Patrick⁵,Yin Hong⁶,Hayashi Masanori⁷^ORCID,Loeb David M.⁸,Smith Tiffany⁹,Makanji Rikesh¹⁰,Fridley Brooke L.¹¹,Wagner Lars M.¹²^ORCID

Affiliation:

1. Department of Pediatric Hematology, Oncology, Bone Marrow Transplantation, and Palliative Care Levine Children's Hospital at Atrium Health Charlotte North Carolina

2. Department of Interdisciplinary Cancer Management Moffitt Cancer Center Adolescent and Young Adult Program Tampa Florida

3. Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation Nationwide Children's Hospital Columbus Ohio

4. Center for Cancer and Blood Disorders Connecticut Children's Medical Center Hartford Connecticut

5. Division of Pediatric Hematology‐Oncology University of North Carolina Health Care Chapel Hill North Carolina

6. Department of Pathology Children's Healthcare of Atlanta Atlanta Georgia

7. Department of Pediatrics Hematology‐Oncology and Bone Marrow Transplant Children's Hospital Colorado Aurora Colorado

8. Department of Pediatrics and Department of Developmental and Molecular Biology Albert Einstein College of Medicine New York City New York

9. National Pediatric Cancer Foundation Tampa Florida

10. Department of Diagnostic Imaging and Interventional Radiology Moffitt Cancer Center Tampa Florida

11. Department of Biostatistics and Bioinformatics Moffitt Cancer Center Tampa Florida

12. Division of Pediatric Hematology‐Oncology Duke Children's Hospital and Health Center Durham North Carolina

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28370

Reference33 articles.

Management of recurrent Ewing sarcoma: challenges and approaches

2. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

3. Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

4. Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas

5. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes;Pediatric Blood & Cancer;2024-07-31

2. A pediatric and young adult case of unclassified renal cell carcinoma with medullary phenotype (RCCU-MP): Clinical course and treatment;Journal of Onco-Nephrology;2024-05-08

3. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs;Frontiers in Pharmacology;2024-01-23

4. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study;British Journal of Cancer;2023-11-01

5. Chemotherapeutic drugs for soft tissue sarcomas: a review;Frontiers in Pharmacology;2023-08-11